CD8A and lymphoma: The antigenicity of ALK associated proteins has been well established in human lymphomas, where T and B cells have been found to be immunoreactive for ALK associated proteins by examining CD8 + CTLs, CD4 + helper T lymphocytes directed against ALK epitopes, and ALK associated antibodies (119, 123).